ProNeurogen, Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$1.94M
Company Overview
ProNeurogen, Inc. operates in Healthcare & Life Sciences and is based in Tucson, Arizona. Its latest recorded funding round was a Grant round in September 2023.
ProNeurogen, Inc. is a biotechnology company that develops novel peptide-based therapeutics to treat vascular dementia, cognitive impairment, and inflammation-related brain disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProNeurogen, Inc. Comparables
Compare ProNeurogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Constant Therapeutics | 80% | |
| NeuroTherapia, Inc. | 78% | |
| Longevity Biotech | 78% |
For institutional investors. Book with your work email.
ProNeurogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | Sep 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProNeurogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 84% MoM, from 113 to 208.
- Jan 26, 2025
Monthly visitors grew 31% MoM.
For institutional investors. Book with your work email.
ProNeurogen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProNeurogen, Inc.'s valuation, stock price, and market status.
Is ProNeurogen, Inc. a public or private company?
ProNeurogen, Inc. is a private company.
What is the current stock price of ProNeurogen, Inc.?
ProNeurogen, Inc. is a private company, so its shares have no public market price. Caplight tracks ProNeurogen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProNeurogen, Inc. worth (valuation)?
Valuation information for ProNeurogen, Inc. is not publicly available.
Can I buy ProNeurogen, Inc. stock?
ProNeurogen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProNeurogen, Inc.'s last funding round?
ProNeurogen, Inc.'s most recent funding round was Grant on November 15, 2023.
Who are the main investors in ProNeurogen, Inc.?
Key investors in ProNeurogen, Inc. include National Institute on Aging, National Institutes of Health (NIH).
Will ProNeurogen, Inc. IPO soon?
No public IPO plans have been announced for ProNeurogen, Inc..
How can I track ProNeurogen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ProNeurogen, Inc.'s shares on secondary markets.